FutureChem Co.Ltd Total Assets
FutureChem Co.Ltd total assets. Based on the latest financial reports, FutureChem Co.Ltd (220100) holds total assets worth ₩69.72 Billion KRW (≈ $47.25 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 220100 market cap overview for the company's overall valuation and market capitalisation.
Total Assets of FutureChem Co.Ltd (2016–2025)
Total assets of FutureChem Co.Ltd from 2016 to 2025. This chart illustrates how FutureChem Co.Ltd's total assets have evolved over time, based on quarterly financial data. See FutureChem Co.Ltd stock quote for real-time trading data and today's change.
FutureChem Co.Ltd - Asset Composition Analysis
FutureChem Co.Ltd Total Assets Breakdown (December 2025)
FutureChem Co.Ltd total assets breakdown as of December 2025. FutureChem Co.Ltd's total assets of ₩69.72 Billion consist of 46.4% current assets and 53.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 5.8% |
| Accounts Receivable | ₩5.33 Billion | 7.2% |
| Inventory | ₩1.56 Billion | 2.1% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩7.71 Billion | 10.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how FutureChem Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore FutureChem Co.Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: FutureChem Co.Ltd's current assets represent 46.4% of total assets in 2025, a decrease from 75.4% in 2016.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2025, down from 52.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 3.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 10.4% of total assets.
FutureChem Co.Ltd Competitors by Total Assets
Key competitors of FutureChem Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
FutureChem Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.54 | 2.30 | 14.84 |
| Quick Ratio | 2.36 | 2.20 | 14.48 |
| Cash Ratio | 0.00 | 0.00 | -0.01 |
| Working Capital | ₩18.29 Billion | ₩22.05 Billion | ₩42.66 Billion |
FutureChem Co.Ltd - Advanced Valuation Insights
This section examines the relationship between FutureChem Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.1% |
| Total Assets | ₩74.53 Billion |
| Market Capitalization | $100.14 Million USD |
Valuation Analysis
Below Book Valuation: The market values FutureChem Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: FutureChem Co.Ltd's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for FutureChem Co.Ltd (2016–2025)
The table below shows the annual total assets of FutureChem Co.Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩74.53 Billion ≈ $50.51 Million |
+0.15% |
| 2024-12-31 | ₩74.42 Billion ≈ $50.43 Million |
+2.18% |
| 2023-12-31 | ₩72.83 Billion ≈ $49.36 Million |
-17.90% |
| 2022-12-31 | ₩88.72 Billion ≈ $60.12 Million |
+15.01% |
| 2021-12-31 | ₩77.14 Billion ≈ $52.27 Million |
-6.45% |
| 2020-12-31 | ₩82.46 Billion ≈ $55.88 Million |
+30.44% |
| 2019-12-31 | ₩63.21 Billion ≈ $42.84 Million |
-1.30% |
| 2018-12-31 | ₩64.05 Billion ≈ $43.40 Million |
+77.91% |
| 2017-12-31 | ₩36.00 Billion ≈ $24.40 Million |
+8.73% |
| 2016-12-31 | ₩33.11 Billion ≈ $22.44 Million |
-- |
About FutureChem Co.Ltd
FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products i… Read more